Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
173 tokens/sec
GPT-4o
7 tokens/sec
Gemini 2.5 Pro Pro
46 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Conditional-Marginal Nonparametric Estimation for Stage Waiting Times from Multi-Stage Models under Dependent Right Censoring (2504.17089v1)

Published 23 Apr 2025 in stat.ME

Abstract: We investigate two population-level quantities (corresponding to complete data) related to uncensored stage waiting times in a progressive multi-stage model, conditional on a prior stage visit. We show how to estimate these quantities consistently using right-censored data. The first quantity is the stage waiting time distribution (survival function), representing the proportion of individuals who remain in stage j within time t after entering stage j. The second quantity is the cumulative incidence function, representing the proportion of individuals who transition from stage j to stage j' within time t after entering stage j. To estimate these quantities, we present two nonparametric approaches. The first uses an inverse probability of censoring weighting (IPCW) method, which reweights the counting processes and the number of individuals at risk (the at-risk set) to address dependent right censoring. The second method utilizes the notion of fractional observations (FRE) that modifies the at-risk set by incorporating probabilities of individuals (who might have been censored in a prior stage) eventually entering the stage of interest in the uncensored or full data experiment. Neither approach is limited to the assumption of independent censoring or Markovian multi-stage frameworks. Simulation studies demonstrate satisfactory performance for both sets of estimators, though the IPCW estimator generally outperforms the FRE estimator in the setups considered in our simulations. These estimations are further illustrated through applications to two real-world datasets: one from patients undergoing bone marrow transplants and the other from patients diagnosed with breast cancer.

Summary

We haven't generated a summary for this paper yet.